Live bladder cancer updates

Live bladder cancer news coverage of developments with the latest updates. Stay on top of latest bladder cancer news stories and find out what just happened, what is going on with bladder cancer. The latest real-time news updates and headlines on bladder cancer
Robotic surgery is safer and improves patient recovery time
Robotic surgery improves patient recovery time
Immunotherapy after bladder cancer surgery reveals excellent cancer-free survival rates
First Mutation-Targeted Bladder Cancer Drug May Be Under-Used
Research in JNCCN encourages harnessing health technology to help cancer patients quit smoking
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Methylation of tRNA-derived fragments regulates gene-silencing activity in bladder cancer
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
Artificial intelligence helps physicians better assess effectiveness of bladder cancer treatment
Cells’ “exosomes” may improve delivery of anticancer drugs to tumors
Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy
Advancing Bladder Cancer Treatment by Studying Biomarkers’ Ability to Respond to Chemotherapy
Anti-cancer dream cream shrinks oral tumors
Potential therapy may boost chemoimmunotherapy response in bladder cancer
When veterinary and human sciences collaborate, cancer patients of all species benefit
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Transparent ultrasound chip improves cell stimulation and imaging
World-first trial of targeted bladder cancer treatment showing promise
MD Anderson receives over $31 million in CPRIT funding
Dana-Farber researchers to present findings at 2022 ASCO Genitourinary Cancers Symposium
UC Davis becomes first in region to grow cancer-fighting CAR T cells
UTA chemists discover potent anti-cancer agent
USANZ and RACGP speak out on pharmacy pilot
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Scientists studying new method to model bladder cancer treatments
How has Covid pandemic impacted diagnosis of new cancers?
Cancer survival rates are improving in Australia
Cancer survival rates continue to improve, while death and incidence rates fall
Researchers develop quicker, more accurate Covid test
Leading researchers team up to bring promising chemotherapy treatment to human trials
2022 Fellowships to support improved health outcomes for cancer patients
Research tackles reducing bladder cancer recurrence
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Attitudes to death and dying in UK
New combination of old drugs improves survival of prostate cancer
Smaller is better for detecting biomarkers of trauma and cancer
Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors
City of Hope study suggests adding drug berzosertib to standard treatment for metastatic bladder cancer does not benefit patients
Research finds biomarker that may help predict benefits of immunotherapy
Blood-pressure drugs could improve colorectal cancer survival
Study: Common Blood Pressure Drugs Could Improve Colorectal Cancer Survival
Experimental drug that boosts immunotherapy reveals promise in bladder cancer study
Researchers find vital enzyme holds key to fight against cancer and viral infections
Women voice frustration over current care for recurrent urinary tract infections
New treatment option for advanced urothelial cancer patients reveals promise in phase 2 clinical trial
Read UK NSC’s annual report for April 2020 to March 2021
Advanced bladder cancers respond to immunotherapy regardless of gene mutation status